SAN FRANCISCO, CA -- (Marketwire) -- 11/29/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:
About MedivationMedivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.
Chief Business & Financial Officer